The American Journal of Managed Care7h
In Myeloid Neoplasms, Next-Generation Sequencing Can Be Inappropriate—and Money-Wasting
A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...
The American Journal of Managed Care1d
Molecular Lesions in Low-Risk Myelodysplastic Neoplasms Disrupt Prognostic Model for Leukemia
Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...
PipelineReview.com2d
Faron Presents Full Analysis of Positive Phase 2 Interim Data from BEXMAB Trial at the 66th American Society of Hematology (ASH) Annual Meeting
The BEXMAB study is a multicenter study, taking place in Finland, UK and the U.S., evaluating the safety and efficacy of bexmarilimab, a novel anti-Clever-1 humanized antibody, with standard of care ...
Sunrise star Edwina Bartholomew reveals why she hasn't told her children about her cancer battle - as she shares her father's heartbreaking reaction to the news
Edwina Bartholomew has shared the reason she has kept her cancer diagnosis a secret from her children. The Sunrise star ...
Sunrise's Edwina Bartholomew gives emotional update on her 'life-changing' cancer battle and shares plans to cut down on TV work amid new role rumours
The Sunrise star, 41, revealed that she had been diagnosed with chronic myeloid leukaemia (CML) - a type of blood and bone ...
Science Daily6d
Changes in blood cell production over the lifetime could impact leukemia outcomes
The first comprehensive map of the dramatic changes that take place in the blood system over the course of the human lifetime could have implications for the treatment of acute myeloid leukemia and ...